Guest View
User: Pass: | become a member
Author Archive for Insider Scoop

Whitney Tilson Says More Confident of Herbalife Short Position Following Ackman Presentation

Courtesy of Benzinga.

Whitney Tilson said in an email Tuesday, that he is more confident in his short position in Herbalife (NYSE: HLF), following Bill Ackman’s presentation. Tilson said he now believes his position has a 76% chance of succeeding vs 63% prior. That’s based on his belief that there is a 95% chance most of the company’s operations are a pyramid scheme, and there is now an 80% chance regulators will intervene.

Herbalife shares rose steadily throughout Ackman’s presentation Tuesday, and end the day up 25% at $77.67

Posted-In: News Movers & Shakers Insider Trades General





Benzinga’s M&A Chatter for Thursday July 10, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday July 10, 2014:

ZF Friedrichshafen Confirms in Talks to Buy TRW Automotive

The Offer:
Shares of TRW Automotive (NYSE: TRW) soared Thursday, on a report from Bloomberg that the company could be acquired for as much as $12 billion by Germany’s ZF Friedrichshafen AG.

TRW later confirmed it had been approached by a potential buyer, followed by Friedrichshafen confirming it was in talks to acquire TRW. Shares of TRW were first halted on a circuit-breaker following the Bloomberg report, eventually hitting a high of $101.98, and then prior to the TRW announcement.

TRW Automotive shares closed off the highs Thursday at $98.91, a gain of more than 8%.

Report PE Firms Have Renewed Interest in Symantec

The Rumor:
Shares of Symantec (NYSE: GME) spiked higher Thursday, on a report from Deal Reporter that the company was in takeover talks with private equity firms, including CVC, Carlyle and Bain. Symantec shareholder Valueact reported a new stake of 7.59 million shares on May 14 and has been seeking changes in the company.

Symantec shares closed Thursday at $22.83, a gain of $0.20.

Crumbs Shares Skyrocket 1200% on Potential Investment

The Investment:
Shares of failed cupcake bakery chain Crumbs (OTC: CRMB) rose 1200% Thursday, hitting a high of $0.55, after closing at just $0.03 on Wednesday, on a report from CNBC that the company was close to securing financing from a group including Marcus Lemonis of CNBC’s “The Profit”. Lemonis plans to move other holdings, including Sweet Pete’s into Crumbs. One of he issues causing problems for Crumbs, was its narrow assortment of product, according to CEO Ed Slezak.

Crumbs announced the closing of its stores on July 7, following its shares being delisted from the Nasdaq on July 1.

Crumbs closed Thursday at $0.40, a gain of $0.37.

Posted-In: News Rumors Management Insider Trades M&A Movers





Benzinga’s M&A Chatter for Wednesday July 9, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday July 9, 2014:

Google Rumored to Have Interest in Deal for Time Warner

The Rumor:
Shares of Time Warner (NYSE: TWX) surged higher Tuesday, following a tweet from Fox Business’ Charlie Gasparino, that he has been hearing chatter of a potential bid from Google (NASDAQ: GOOG). Time Warner shares hit a high of $73.07.

Wall Street Journal reporter Doug MacMillan later tweeted that Time Warner’s CEO said his company was not in talks with Google.

Time Warner shares closed off the highs Wednesday at $72.41, a gain of more than 2%.

Hearing Potential Bid for GameStop

The Rumor:
Shares of GameStop (NYSE: GME) spiked higher Wednesday, on renewed unconfirmed market chatter of a potential bid from an unnamed suitor. Chatter had surfaced on June 22 that GameStop had hired an advisor to help it to review strategic alternatives.

A spokesperson for GameStop was unavailable for comment.

GameStop shares closed Wednesday at $41.79, a gain of $0.15.

AbbVie Forced to Retract Comments Regarding Shire Takeover Attempt

The Withdrawn Comments:
AbbVie (NYSE: ABBV) CEO Richard Gonzalez was forced to withdraw comments he made regarding shareholder support for his company’s bid for Shire (NASDAQ: SHPG). The comments were a violation of UK Takeover Panel rules, as the support was not in writing.

AbbVie confirmed today, it had not received commitments of support in writing.

Shire closed Wednesday at $235.08, a gain of almost 1%, while AbbVie lost more than 1% to close at $55.01.

Shareholders Urge Allergan to Make Acquisitions

The CEO Comments:
Allergan (NYSE: AGN) shareholders are encouraging the company to make a large acquisition in order to fight off a $53 billion hostile takeover bid from Valeant Pharmaceuticals (NYSE: VRX) and investor Bill Ackman of Pershing Square, according to a report from Financial Times. Allergan CEO David Pyott, said his company should act quickly in making an acquisition, based on comments from shareholders.

Allergan’s board rejected Valeant’s latest bid of $53 billion in cash and Valeant shares on June 23.

Allergan closed Wednesday at $165.20, a loss of $0.87, while Valeant lost 1% to close at $120.94.

Posted-In: News Hedge Funds Rumors Movers & Shakers Management Insider Trades Movers General





Arena Pharmaceutical Shares Dive On News CEO Sold 40% Of His Shares

Courtesy of Benzinga.

Related ARNA
Benzinga's Top #PreMarket Losers
Markets Marginally Lower Ahead Of Earnings Season

Arena Pharmaceuticals (NASDAQ: ARNA) shares plunged Monday on news that its chief executive Jack Lief sold nearly 40 percent of his holdings in the company.

Lief sold 223,525 shares on July 1 at $5.85 per share. The transaction was an "automatic sell" apparently triggered by a declining share price.

While unusual, the transaction isn't unique among Arena's insider deals. Dominick Behan sold 200,000 shares at $6.30 per share in October, according to filings.

"Lief dumping 40% of his Arena shares all at once when the stock is hitting new lows isn't exactly confidence inspiring," wrote TheStreet columnist Adam Feuerstein.

Feuerstein said the transaction is the death knell of intermittent rumors that Eisai Co. (OTC: ESALY) will acquire Arena.

After opening sharply lower Monday, Arena traded recently at $5.33, down 8.73 percent.

Posted-In: News Insider Trades Movers





American Apparel, Phillips 66 And Others Insiders Have Been Buying

Courtesy of Benzinga.

Related AAP
Worst Performing Industries For July 22, 2014
American Apparel Signs Support Agreement With Standard General

American Apparel, Consolidated Edison and Phillips 66 are among the companies that have seen insider buying recently. Insiders may sell shares for any number of reasons, but conventional wisdom says that insiders really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it.

Pullbacks and sell-offs provide a perfect opportunity for investors who have faith in a company to snap up shares.

Accelerate Diagnostics

Recently, one director and one beneficial owner have picked up more than 38,000 Accelerate Diagnostics (NASDAQ: AXDX) shares combined for a total price of almost $1 million. Note that the same beneficial owner also bought $5 million worth of shares back in May.

This Arizona-based medical research company has a market cap of a little over $1 billion and a return on equity that is in the red. Short interest is more than 10 percent of the total float. Shares have pulled back more than 12 percent from a recent 52-week high. Over the past six months, the stock has outperformed the S&P 500.

American Apparel

Ousted CEO Dov Charney recently scooped up more than 27.3 million shares of American Apparel (NYSE: AAP) as part of his attempt to get the company back. That was worth more than $19.5 million. Hedge fund Standard General is helping Charney, and also bought about 1.5 million shares since.

The market cap is about $9.8 billion. The return on equity is more than 100 percent, but the operating margin is in the red. The share price has swung wildly since Charney's ouster, and over the past six months, the stock has underperformed the likes of Abercrombie & Fitch and Urban Outfitters.

See also: American Apparel Imperiled By Lender's Repayment Demand

Consolidated Edison

A number of executives, including…
continue reading





Benzinga’s Weekend M&A Chatter

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday June 27 through Sunday June 29, 2014:

Tencent Acquires Approximately 20% Stake in 58.com for $736M

The Deal:
58.com (NYSE: WUBA) and Tencent Holdings (OTC: TCEHY) announced Friday that Tencent has agreed to invest $736 million in exchange for approximately 19.9% equity interest in 58.com. Under the agreement, Tencent is purchasing 36.805M Class A and B ordinary shares at $20 per share, or $40 per ADS. 58.com will use part of the proceeds from this transaction to buyback 27,603 million shares from existing pre-IPO shareholders.

58.com closed Friday at $54.90, a gain of 5%.

Rackspace Shares Fall on Reported Lack of Takeover Interest

The Rumor:
Shares of Rackspace (NYSE: RAX) fell sharply Friday, on a report from Deal Reporter that there has been a lack of interest from potential buyers for the web hosting company, due to cash flow issues. Rackspace has been the subject of frequent takeover chatter, with IBM (NYSE: IBM) being often mentioned as a potential suitor.

Rackspace closed Friday at $33.63, a loss of more than 7%.

Pershing Square Settles Poison Pill Litigation

The Settlement:
Bill Ackman’s Pershing Square Capital Management announced Friday, it has reached a settlement with Allergan (NYSE: AGN), resolving the previously announced poison pill litigation before the Delaware Court of Chancery.

The settlement provides that Pershing Square’s solicitation and receipt of revocable proxies to call a special meeting of shareholders of Allergan will not trigger the poison pill, and paves the way for Pershing Square to begin actively soliciting proxies to call the special meeting.

Allergan has rejected Valent Pharmaceutical’s takeover bids, the current offer being $53 billion in cash and Valeant shares. The rejections have prompted Ackman and Valeant to present the offer directly to Allergan shareholders.

Allergan closed Friday at $173.95, a gain of 2%, while Valeant closed at $128.85, a gain of almost 2%.

Posted-In: News Hedge Funds Rumors Movers & Shakers Management Insider Trades M&A General





Benzinga’s M&A Chatter for Tuesday June 24, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday June 24, 2014:

Endo International to Acquire DAVA Pharma for $575M Cash and Up to $25M in Milestone Payments

The Deal:
Endo International (NASDAQ: ENDP) announced Tuesday that it has agreed to acquire privately-held DAVA Pharmaceuticals for $575 million in cash, plus additional cash consideration of up to $25 million contingent on achieving certain sales milestones. The deal is expected to close in H2 of 2014.

Endo International closed Tuesday at $70.26, a gain of more than 2%.

ARC Group Announces Acquisition of Kecy Corporation For $26M

The Deal:
ARC Group Worldwide (ARCW) announced Tuesday, it has agreed to acquire precision metal stamping company, Kecy Corporation for $26 million in cash. The closing of the Kecy Acquisition is expected to occur on June 25, 2014.

ARC Group closed Tuesday at $17.54, a gain of almost 2%.

IMS Health to Acquire Cegedim’s Information Solutions and CRM Businesses for $520M in Cash

The Deal:
IMS Health (NYSE: IMS) announced Tuesday, its intention to acquire certain Cegedim information solutions and Customer Relationship Management businesses for approximately $520 million in cash. The deal is expected to close in early 2015.

IMS Health closed Tuesday at $23.21, and traded as high as $24.76 after-hours.

Valeant CEO Says Major Allergan Shareholders Support $53B Proposal

The CEO Comments:
Shares of Allergan (NYSE: AGN) spiked higher Tuesday, on comments by Valeant (NYSE: VRX) CEO Pearson, that major Allergan shareholders supported the $53 billion bid by Valeant, and the company would soon have enough support for an Allergan shareholder vote on the hostile takeover attempt. Pearson also said Valeant was pursuing no other large deals, while they are working on completing the Allergan deal.

25% of Valeant shareholders are needed to convene the vote. Activist investor Bill Ackman holds almost a 10% stake in Allergan.

Allergan closed Tuesday at $165.35, a gain of $0.53. Valeant closed at $120.52, a loss of $0.69.

Report Aetna Considers Sale of Coventry Health Care Assets Valued at $1.5B

The Rumor:
Aetna (NYSE: …
continue reading





Benzinga’s M&A Chatter for Tuesday July 22, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday July 22, 2014:

CIT Group to Acquire OneWest Bank for $3.4B in Cash, Stock

The Deal:
CIT Group (NYSE: CIT) announced Tuesday, that it has entered into a definitive agreement and plan of merger with the parent company of privately-held OneWest Bank for $3.4 billion in cash and stock. Under the terms of the agreement, Shareholders of OneWest’s parent company, IMB Holdco, will receive $2 billion in cash and 31.3 million shares of CIT Group common stock.

The deal has been approved by both company’s Boards of Directors.

CIT Group closed Tuesday at $48.71, a gain of almost 11%.

LinkedIn Announces Purchase of Bizo, Valued at $175M

The Deal:
LinkedIn (NYSE: LNKD) announced Tuesday, that it has agreed to acquire Bizo, in a deal valued at approximately $175 million, cosnisiting of approximately 10 percent stock and approximately 90 percent cash. The deal is expected to close Q3 of 2014.

LinkedIn closed Tuesday at $165.50, a gain of 2%.

Report Respsol May Explore Talisman Energy Bid

The Rumor:
Shares of Talisman Energy (NYSE: TLM) spiked higher after-hours Tuesday, on a report from Bloomberg that Spain’s Repsol (OTC: REPYY) may explore a bid for the Canadian oil and gas company. Repsol is reportedly looking for a place to put its cash, following the loss of its stake in YPF (NYSE: YPF), according to sources.

Talisman shares closed Tuesday at $9.85, and gained 11% after-hours.

Report PetSmart Hires JPMorgan to Explore Potential Deal

The Rumor:
PetSmart (NASDAQ: PETM) has reportedly hired JPMorgan Chase to consider strategic alternatives, including a potential sale, according to a report Tuesday from Reuters. Two of PetSmart’s largest shareholders, Jana Partners and Longview Asset Management, with a combined 20% stake, have urged PetSmart to consider a sale. Dow Jones reported on July 17 that PetSmart was interviewing investment banks.

PetSmart closed Tuesday at $69.34, a gain of $.18.

Posted-In: News Rumors M&A Movers





Summit Research Weighs In On Applied Materials, Tokyo Electron Merger

Courtesy of Benzinga.

Related AMAT
Stocks Rebound From 2 Day Drop As The Fed Confirms The End Of QE Is Near
Memories Of March Return As Momentum Stocks Hit Hard
Week Ahead: Inflation Data and Wal-Mart Earnings (Fox Business)

DealReport is out with a note commenting the cross-border merger of the two largest semiconductor equipment firms, Applied Materials (NASDAQ: AMAT) and Tokyo Electron.

Summit Research Partners analyst Srini Sundararajan said Tokyo Electron is serious about making a deal. Commenting on Tokyo Electron's lack of performance and dwindling business, the analyst wrote:

"Lastly, the Tokyo Electron of today is not the Tokyo Electron of Japan's glory days; just like some of the semiconductor manufacturers it is also hurting a bit, having recovered from the great earthquake of 2011 and its place is as a part of a bigger company."

The merger is waiting on approval from regulators. Sundararanjan sees an Applied Materials/Tokyo Electron merger as containing less overlap and less monopolistic worry than other deals that have been approved in the sector, such as Advantest/Verigy or KLA-Tenco/Thermawave.

Posted-In: Srini Sundararajan Summit Research PartnersNews Rumors M&A





Notable Hedge Fund May Have Taken New Position In Apache

Courtesy of Benzinga.

Related APA
Earnings Season Boosts Confidence; S&P Trades At Record Highs
Bank Of America Suggests 'Not Chasing Move' On Apache Activist Investor
Energy Stocks Move Higher as Oil Spikes (Fox Business)

Shares of Apache Corp. (NYSE: APA) have rocketed higher in Monday’s post-market session following word of a new stake from Barry Rosenstein and JANA Partners.

According to Bloomberg headlines which hit just ahead of 5 p.m. EDT, JANA’s latest shareholder letter for the second quarter of 2014 showed a brand-new activist stake in Apache. The rumored investment by JANA in Apache sits at around $1 billion, Bloomberg said. This would make the position in Apache the fund’s largest purchase during the second quarter.

Apache shares last traded at $101.50, up about three percent from Friday’s closing price.

Posted-In: News Hedge Funds Rumors Movers General





 

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743"

Thank you for you time!

 
 

Phil's Favorites

Ukraine Caught in Third Major Lie? Magic Number 312

Courtesy of Mish.

I have strong evidence from Ukrainian citizen Anatoly Shary that Kiev is caught in a third major lie regarding Buk deployment.

It takes a while to go over the evidence, condensed below, all having to do with the number 312 painted on a missile launcher.

Follow the Number

On March 8, Censor.Net, a Ukrainian Nationalist cite, says "Ukraine Defends Donetsk From Russian Incursion: 'Buk' Air Defense Rocket Systems Are Taking Up Positions. PHOTO + VIDEO"

The sub-headline reads: "A resident of Gorlovka, driving to work in Soledar, came across an entire convoy of military equipment. ...My coworkers and I counted 11 missile launchers ..."
...



more from Ilene

Insider Scoop

Relaxed Regulations Highlight Nuclear ETFs

Courtesy of Benzinga.

The Environmental Protection Agency is considering a review of its 1977 rule that limits the amount of whole-body radiation that any member of the public can be exposed to as a result of the uranium fuel cycle.

While they have not made any immediate determination to change the current level of 0.25 millisieverts per year of allowable radiation, they are reviewing the scientific data to decide if changes need to be made.

Items under review include water resource protection, spent fuel storage facilities and alternative technologie...



http://www.insidercow.com/ more from Insider

Zero Hedge

The Stealing Of America By The Cops, The Courts, The Corporations And Congress

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Submitted by John Whitehead via The Rutherford Institute,

“What the government is good at is collecting taxes, taking away your freedoms and killing people. It’s not good at much else.” —Author Tom Clancy

Call it what you will—taxes, penalties, fees, fines, regulations, tariffs, tickets, permits, surcharges, tolls, asset forfeitures, foreclosures, etc.—but the only word that truly describes the constant bilking of the American taxpayer by the government and its corporate partners is th...



more from Tyler

Chart School

S&P 500 Snapshot: An Intraday Record High

Courtesy of Doug Short.

The pre-open release of the Consumer Price Index showed core inflation in June to be a tad lighter than forecasts. The S&P 500 opened at its 0.10% intraday low and rallied to its 0.64% record intraday high about ninety minutes into the session. Strong existing home sales announced at 10 AM certainly helped. The index spent the rest of the day in a narrow trading range and closed with a 0.50% gain, a mere 0.10% off its record close of July 3rd.

The yield on the 10-year note ended the day at 2.48%, 1 bp below yesterday's close. It is now only 4 bps above its interim closing low of May 28th.

Here is a 15-minute chart of the past five sessions. The S&P 500 is up 7.31% year-to-date.

Volume on the SPY ETF, whi...



more from Chart School

Option Review

Sizable Call Spread Trades On Orexigen

A large call spread initiated on Orexigen Therapeutics, Inc. (Ticker: OREX) on Monday morning looks for shares in the name to rally approximately 30% by September expiration. The September expiration is noteworthy as the company awaits the results of the FDA’s review of its resubmitted New Drug Application (NDA) for NB32, an investigational medication being evaluated for weight loss, after the review was extended for three months back in June. The upcoming Prescription Drug User Fee Act (PDUFA) date is September 11, 2014, according to a press release issued by the company. Shares in Orexigen today are up roughly 0.40% at $5.34 as of 2:15 p.m. ET.

...

more from Caitlin

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Sabrient

Sector Detector: Bulls remain unfazed by borderline Black Swans

Courtesy of Sabrient Systems and Gradient Analytics

Despite a highly eventful week in the news, not much has changed from a stock market perspective. No doubt, investors have grown immune to the daily reports of geopolitical turmoil, including Ukraine vs. Russia for control of the eastern regions, Japan’s dispute with China over territorial waters, Sunni vs. Shiite for control of Iraq, Christians being driven out by Islamists, and other religious conflicts in places like Nigeria and Central African Republic. But last Thursday’s news of the Malaysian airliner tragically getting shot down over Ukraine, coupled with Israel’s ground incursion into Gaza, had the makings of a potential Black Swan event, which in my view is the only thing that could derail the relentless bull march higher in stocks.

Nevertheless, when it became clear that the airline...



more from Sabrient

OpTrader

Swing trading portfolio - week of July 21st, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

Here's the latest Stock World Weekly. Please use your PSW user name and password to log in. (You may take a free trial here.)

#452331232 / gettyimages.com ...

more from SWW

Market Shadows

Danger: Falling Prices

Danger: Falling Prices

By Dr. Paul Price of Market Shadows

 

We tried holding up stock prices but couldn’t get the job done. Market Shadows’ Virtual Value Portfolio dipped by 2% during the week but still holds on to a market-beating 8.45% gain YTD. There was no escaping the downdraft after a major Portuguese bank failed. Of all the triggers for a large selloff, I’d guess the Portuguese bank failure was pretty far down most people's list of "things to worry about." 

All three major indices gave up some ground with the Nasdaq composite taking the hardest hi...



more from Paul

Digital Currencies

Bitcoin Vs Gold - The Infographic

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

While Marc Faber has said "I will never sell my gold," he also noted "I like the idea of Bitcoin," and the battle between the 'alternative currencies' continues. The following infographic provides a succinct illustration of the similarities and differences between gold and bitcoin.

Please include attribution to www.jmbullion.com with this graphic.

...

more from Bitcoin

Pharmboy

Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...



more from Pharmboy

Promotions

See Live Demo Of This Google-Like Trade Algorithm

I just wanted to be sure you saw this.  There’s a ‘live’ training webinar this Thursday, March 27th at Noon or 9:00 pm ET.

If GOOGLE, the NSA, and Steve Jobs all got together in a room with the task of building a tremendously accurate trading algorithm… it wouldn’t just be any ordinary system… it’d be the greatest trading algorithm in the world.

Well, I hate to break it to you though… they never got around to building it, but my friends at Market Tamer did.

Follow this link to register for their training webinar where they’ll demonstrate the tested and proven Algorithm powered by the same technological principles that have made GOOGLE the #1 search engine on the planet!

And get this…had you done nothing b...



more from Promotions



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>